Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124050362 | 12405036 | 2 | F | 2014 | 20160706 | 20160525 | 20160712 | EXP | US-ASTRAZENECA-2016SE55378 | ASTRAZENECA | 58.00 | YR | F | Y | 81.60000 | KG | 20160712 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124050362 | 12405036 | 1 | PS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 19810 | 20 | MG | QD | ||||||
| 124050362 | 12405036 | 2 | SS | PRILOSEC OTC | OMEPRAZOLE MAGNESIUM | 1 | Oral | Y | U | 0 | 20 | MG | MODIFIED-RELEASE TABLET | QD | |||||
| 124050362 | 12405036 | 3 | SS | PRILOSEC OTC | OMEPRAZOLE MAGNESIUM | 1 | Oral | Y | U | 0 | 20 | MG | MODIFIED-RELEASE TABLET | BID | |||||
| 124050362 | 12405036 | 4 | SS | ANTIHYPERTENSIVES | UNSPECIFIED INGREDIENT | 1 | Unknown | 3 DIFFERENT MEDICINES FOR HIGH BP-1/DAY | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124050362 | 12405036 | 1 | Gastrooesophageal reflux disease |
| 124050362 | 12405036 | 2 | Gastrooesophageal reflux disease |
| 124050362 | 12405036 | 3 | Gastrooesophageal reflux disease |
| 124050362 | 12405036 | 4 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124050362 | 12405036 | HO |
| 124050362 | 12405036 | OT |
| 124050362 | 12405036 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124050362 | 12405036 | Asthenia | |
| 124050362 | 12405036 | Blood magnesium decreased | |
| 124050362 | 12405036 | Blood potassium decreased | |
| 124050362 | 12405036 | Fatigue | |
| 124050362 | 12405036 | Hypertension | |
| 124050362 | 12405036 | Nausea | |
| 124050362 | 12405036 | Overdose | |
| 124050362 | 12405036 | Pain | |
| 124050362 | 12405036 | Product use issue | |
| 124050362 | 12405036 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124050362 | 12405036 | 3 | 201502 | 0 |